Venkatesh Prasanna arrests two more suspects in Malleswaram blast case

Mangaluru, May 19: With lockdown 4.0 coming into force, the Karnataka State Road Transport Corporation (KSRTC) started bus services from Mangaluru to various destinations today.

According to officials, buses started plying from Mangaluru to Bengaluru, Mysuru, Shivamogga, Hubballi and other areas with limited passengers. A bus, which left for Bengaluru from Mangaluru had less than 30 passengers on board.

“Depending on the demand, the buses will be operated with 50% of the capacity. Measures have been taken to ensure that social distancing norms are adhered to while purchasing tickets from the counter,” said S N Arun, KSRTC Divisional Controller.

However, the KSRTC is yet to take a decision on operating Nagarasarige buses in the city. 

“Only those destinations, which can be reached by 7 pm has been considered by the KSRTC while operating the buses. As a result, after 11 am, no buses will travel to Bengaluru from Mangaluru. Further, permission will not be accorded for the travelling of pregnant women, children below 10 years old and senior citizens above 60 years old. Thermal scanning is used for checking the temperature of the passengers before boarding the buses. All the buses are sanitised after each trip,” he said.

Further, he said the contact number, name and address of the passengers are collected by the officials during the travel.

Vijayapura, June 16: Even as a video of a man wearing a burqa who is being thrashed by locals is going viral on social media, netizens targeted Bharatiya Janata Party for their activist resorting to heinous acts. 

The man who was caught in burqa has been identified as Siddu Paragond, an activist of Snagh Parivar hailing from Sindgi town in Karnataka’s Vijayapura district. 

The bizarre incident took place in Sindgi on June 11 outside a bank.

“While people including women were standing in a queue outside the bank, the person in burqa was acting in a suspicious manner. The person was trying to get too close to women which was making them feel awkward,” local residents said.

“Getting suspicious, some locals tried to interact and their suspicion rose with the strange behaviour of the person. Suddenly some men took the person away from the bank and checked only to find that it was a man in burqa. The men thrashed him and handed him over to police,” the sources said.

Confirming this, Superintendent of Police Anupam Agrawal said that the Siddu Paragond has been arrested and remanded to judicial custody. He, however, made it clear that no suspicious objects were found on Siddu. “We are trying to find out the motive for his act,” the SP said.

University of Oxford researchers have claimed that a cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

Scientists working on the Recovery Trial found the drug could help patients on ventilators and oxygen, but had no effect on those who did not need help breathing.

“Based on these results, one death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” researchers said in a statement.

Matt Hancock, the health secretary, tweeted: “This global first exemplifies the power of science.”

“I’m absolutely delighted that today we can announce the first successful clinical trial for a treatment for Covid-19,” Mr Hancock said.

Recovery Trial experts said a randomised group of 2,104 patients was given 6mg of dexamethasone per day for 10 days, while another group of 4,321 were given normal treatment.

Dexamethasone reduced deaths by one-fifth in patients on oxygen feeds and by one-third in those who needed a ventilator to breathe, preliminary results showed.

Mr Hancock added: “This is a huge step forward and it’s because we’ve backed the science.”

Martin Landray, professor of medicine and epidemiology at the Nuffield Department of Population Health, University of Oxford, and one of the trial’s chief investigators, said in a statement: “These preliminary results from the Recovery Trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications.

“Covid-19 is a global disease – it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide.”